The contribution of the anaesthetist to risk-adjusted mortality after cardiac surgery. by Papachristofi, O et al.
Papachristofi, O; Sharples, LD; Mackay, JH; Nashef, SA; Fletcher,
SN; Klein, AA; Association of Cardiothoracic Anaesthetists (ACTA),
; , COLLABORATORS; Lau, G; Woodward, D; Hillier, J; Ware, M;
Agarwal, S; Bill, M; Gill, R; Duthie, D; Skinner, H (2015) The con-
tribution of the anaesthetist to risk-adjusted mortality after cardiac
surgery. Anaesthesia, 71 (2). pp. 138-46. ISSN 0003-2409 DOI:
https://doi.org/10.1111/anae.13291
Downloaded from: http://researchonline.lshtm.ac.uk/4648340/
DOI: 10.1111/anae.13291
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
Original Article
The contribution of the anaesthetist to risk-adjusted mortality
after cardiac surgery*
O. Papachristoﬁ,1 L. D. Sharples,2 J. H. Mackay,3 S. A. M. Nashef,4 S. N. Fletcher5 and A. A. Klein3
on behalf of the Association of Cardiothoracic Anaesthetists (ACTA)a
1 PhD Student, MRC Biostatistics Unit, Institute of Public Health, Cambridge, UK
2 Professor of Statistics and Director of Comprehensive Health Research Division, Clinical Trials Research Unit,
University of Leeds, Leeds, UK
3 Consultant, Department of Anaesthesia and Intensive Care, 4 Consultant, Department of Cardiothoracic Surgery,
Papworth Hospital, Cambridge, UK
5 Consultant, Departments of Anaesthesia and Critical Care, St Georges University Hospital, London, UK
Summary
It is widely accepted that the performance of the operating surgeon affects outcomes, and this has led to the publica-
tion of surgical results in the public domain. However, the effect of other members of the multidisciplinary team is
unknown. We studied the effect of the anaesthetist on mortality after cardiac surgery by analysing data collected
prospectively over ten years of consecutive cardiac surgical cases from ten UK centres. Casemix-adjusted outcomes
were analysed in models that included random-effects for centre, surgeon and anaesthetist. All cardiac surgical opera-
tions for which the EuroSCORE model is appropriate were included, and the primary outcome was in-hospital death
up to three months postoperatively. A total of 110 769 cardiac surgical procedures conducted between April 2002
and March 2012 were studied, which included 127 consultant surgeons and 190 consultant anaesthetists. The over-
whelming factor associated with outcome was patient risk, accounting for 95.75% of the variation for in-hospital
mortality. The impact of the surgeon was moderate (intra-class correlation coefﬁcient 4.00% for mortality), and the
impact of the anaesthetist was negligible (0.25%). There was no signiﬁcant effect of anaesthetist volume above ten
cases per year. We conclude that mortality after cardiac surgery is primarily determined by the patient, with small
but signiﬁcant differences between surgeons. Anaesthetists did not appear to affect mortality. These ﬁndings do not
support public disclosure of cardiac anaesthetists’ results, but substantially validate current UK cardiac anaesthetic
training and practice. Further research is required to establish the potential effects of very low anaesthetic caseloads
and the effect of cardiac anaesthetists on patient morbidity.
.................................................................................................................................................................
Correspondence to: A. A. Klein
Email: andrew.klein@nhs.net
Accepted: 18 September 2015
*Presented in part at the joint meeting of the Association of Cardiothoracic Anaesthetists and the Society of Cardiotho-
racic Surgeons, April 2015, Manchester, UK.
aSee Appendix 1 for the list of collaborators.
This article is accompanied by an editorial by Alston, Anaesthesia 2016; 71: 123–6.
138 © 2015 The Authors. Anaesthesia published by John Wiley & Sons Ltd on behalf of Association of Anaesthetists of Great Britain and Ireland
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and
distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Anaesthesia 2016, 71, 138–146 doi:10.1111/anae.13291
Introduction
It is accepted that the operating surgeon may affect
risk-adjusted mortality following cardiac surgery, and
this has led to the publication of surgeon-speciﬁc mor-
tality rates in the UK and elsewhere (see http://
www.scts.org/patients/hospitals/) [1, 2]. The fact that
cardiac surgery is undertaken by teams has inevitably
led to the suggestion that other team members – nota-
bly the anaesthetist – should be subject to similar scru-
tiny, and that anaesthetist-speciﬁc, risk-adjusted
outcomes should be similarly available [3–6].
Objective evaluation of the contribution of individ-
ual anaesthetists to postoperative outcome is difﬁcult.
A link between the individual anaesthetist and out-
comes (myocardial ischaemia and infarction) was sug-
gested 30 years ago in a landmark study by Slogoff
and Keats [7]. Merry et al. demonstrated a potential
link between patient outcome and individual anaes-
thetists [8], but the topic received scant attention over
the next two decades. Two recent attempts to assess
the impact of the anaesthetist on cardiac surgical out-
comes have produced conﬂicting results. A single-cen-
tre UK study of 18 662 patients found that the
individual anaesthetist had a minimal impact on risk-
adjusted mortality [9]. In contrast, a North American
retrospective observational study of 7920 patients,
based on prospectively collected data from the New
York State Cardiac Surgery Reporting System, found
evidence of substantial variability in death or major
complications between anaesthetists [10]. A possible
explanation for the apparent transatlantic differences
in the impact of the anaesthetist is the difference in
anaesthetic practice. In the UK study centre, anaes-
thetists’ workload was entirely cardiothoracic, largely
protocol-driven and cardiac caseload was high. In con-
trast, in the North American study, many anaesthetists
had mixed practices, lower annual cardiac caseloads
and greater variation in protocols.
In surgery, mortality may be inversely related to
caseload volume [11, 12]. The analogous impact of
anaesthetic caseload volume is unexplored. Cardiotho-
racic anaesthesia and intensive care has developed into
a sub-speciality in its own right, and this has led to a
debate as to whether anaesthetists should also under-
take a minimum annual caseload.
We were motivated by the hypotheses that there
may be variation in cardiac surgical outcomes between
anaesthetists as there is between surgeons, and that
caseload volume may be associated with patient out-
comes. Hence, the aim of our study was to assess the
anaesthetists’ impact on the variation in outcomes after
cardiac surgery and to establish whether caseload vol-
ume may affect patient outcome.
Methods
All 36 UK specialist cardiac surgical centres were
invited to take part in the study; a time frame of
one month was given to respond and to secure rele-
vant permissions. Of the 36 centres, ten volunteered
for participation (Bristol University Hospital, Cardiff
University Hospital, City Hospital Nottingham, Glen-
ﬁeld Hospital Leicester, Leeds General Inﬁrmary,
Liverpool Heart and Chest Hospital, Northern General
Hospital Shefﬁeld, Papworth Hospital Cambridge,
Royal Victoria Hospital Belfast, and Southampton
University Hospital), and obtained the relevant local
permissions for data collection within the set time
frame. The requirement for formal ethical approval
was waived according to the National Research Ethics
Service of the NHS Health Research Authority. All
centres collected data prospectively as part of NHS
requirements and provided these data to the Society of
Cardiothoracic Surgeons and National Institute for
Cardiovascular Outcomes Research; these datasets were
then provided to the Association of Cardiothoracic
Anaesthetists (ACTA) in 2014. Data from consecutive
major cardiac operations were prospectively collected
for the period April 2002 through March 2012 (Fig. 1),
with the exception of centre no. 4 (April 2002 through
March 2013), and centre no. 8 (April 2004 through
August 2013). Cardiac transplants, pulmonary
endarterectomy procedures, very high-risk cases that
required operation by two or more consultant sur-
geons, and other procedures for which the logistic
EuroSCORE [13] was not suitable, were not studied.
Patients under 18 years of age were also not studied.
The primary outcome measure was in-hospital
death up to three months postoperatively; patients
who were transferred out of the hospital in which they
had their surgery to another hospital were considered
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to have survived. The logistic EuroSCORE was used to
adjust for different patient casemix; this is a very
well-established risk score, given as a percentage,
speciﬁcally constructed to be used as a risk predictor
for in-hospital death after cardiac operations. It
includes 17 cardiac, operation- and patient-related fac-
tors and is used for risk assessment in many countries.
This is the principal patient covariate we considered
and it should be sufﬁcient since all important patient-
related factors for in-hospital mortality were included
in its construction, with appropriate weighting [13,
14]. Although the original logistic EuroSCORE [13]
has been recalibrated (EuroSCORE-2 [14]), the original
version was in use during this study and was the ver-
sion supplied by participating centres. The primary
covariate of interest was the caseload volume of anaes-
thetists and surgeons.
We used logistic random-effects regression analysis
[15–17] to analyse the relationship between in-hospital
death and potential covariates. The response was death
within three months of the procedure. Our analysis
reﬂected the hierarchical nature of the data (patients
Consecutive cardiac cases 
n = 115 254 
Duplicated 
n = 366 (0.3%)
Individual procedures
n = 114 888  
Patients under 18 years old or missing 
surgeon, anaesthetist, EuroSCORE or 
outcome 
n = 3916 (3.4%)
n = 110 972
Surgeons or anaesthetists with 
very small caseloads
n = 203 (0.2%)
n = 110 769
Figure 1 Flow diagram of participants.
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grouped within surgeons/anaesthetists who are
grouped within centres) using ‘random-effects’ for cen-
tres, surgeons, and anaesthetists. The logistic Euro-
SCORE was included as a ﬁxed effect in all models to
standardise for different patient risk-proﬁles; this was
achieved by dividing the scores by 100 to transform
them to probabilities and taking their logit transform.
We ﬁrst ﬁtted two three-level, random intercept
models to establish the effects of individual surgeon
and anaesthetist on the patient outcome, controlling
for centre effects and casemix risk. To investigate the
combined effects of surgeon and anaesthetist, we ﬁtted
a three-level, cross-classiﬁed model assuming an addi-
tive, individual contribution from each provider
(anaesthetist and surgeon), nested with centres. To
investigate the effect of volume on outcome, we reﬁt-
ted the three-level, cross-classiﬁed model including the
monthly average volume of cases per surgeon and
anaesthetist, deﬁned as the total number of operations
performed divided by the number of months in active
practice. For each model, the intra-class correlation
coefﬁcients (ICC) [17] were estimated, interpreted as
the proportion of the total variation that can be attrib-
uted to each of the anaesthetist, surgeon and centre.
The p values determining the signiﬁcance of the ﬁxed-
effect terms were calculated using the likelihood ratio
test. Analyses were implemented using R (version
3.0.1, see http://www.r-project.org) [18, 19].
When reporting the results, we have not provided
95% CI. Conﬁdence intervals for the proportion of the
variation explained by different components in a hier-
archical dataset are extraordinarily difﬁcult to estimate.
The technical statistical derivation has not been pub-
lished (to our knowledge). We can never show that a
variance component is zero, or even that a CI includes
zero. Software does not normally provide standard
errors for the random-effects variance either, and only
a likelihood ratio test is recommended to judge the
signiﬁcance of the random-effects terms.
Results
There were missing outcomes of interest, for which
records could not be retrieved, in three centres. Since
the proportions of missing data from these three
centres were very small (0.01%, 0.01% and 1.5% of
n = 9900, 18 515 and 7793, respectively), we removed
cases with missing outcome from the dataset. In four
centres, a small number of missing surgeon entries
were found (0.01%, 0.04%, 0.02% and 0.2% of
n = 15 461, 7793, 9900 and 6903, respectively), and
these were excluded from the analysis. Eight of the ten
centres had missing anaesthetist entries, with the lar-
gest proportion reaching 3% in centre no. 6
(n = 9900); the percentages in other centres varied
from 0.1% to 1.5%. Since the anaesthetist could not be
informatively imputed and these percentages were
small, these cases were excluded. Finally, missing Euro-
SCORE entries from ﬁve centres (0.03%, 0.7%, 1.2%,
1.9% and 5.0% of n = 6625, 9900, 9633, 7501 and
7793, respectively) were removed from the data.
In all centres, surgeons and anaesthetists who each
performed < 0.1% of the cases in their centre were
excluded; this was fewer than 10 operations per profes-
sional except for one surgeon. These professionals had
either retired just after the start of the study period,
were appointed just before the end of the study period,
or held short-term contracts at their centre.
Final analysis was performed on 110 769 cases
after exclusions, 96% of the original case series of
115 254 patients, treated by 127 surgeons and 190
anaesthetists in ten centres. The analysis was done
using 91% (127/140) and 76% (190/250) of the original
surgeon and anaesthetist samples, respectively, mostly
due to the low-volume exclusions. Baseline characteris-
tics for the study cohort are summarised in Table 1.
Overall, 3413 of 110 769 patients (3.1%) died in-hospi-
tal. In-hospital mortality for the subset of professionals
with very small caseloads was comparable with mortal-
ity in individual centres (3.45% of n = 203, see
Table 2) as well as overall mortality for this dataset.
The cases performed in each centre are summarised in
Table 2, together with death rates, EuroSCORE and
number of surgeons and anaesthetists per centre. For
one centre, the additive EuroSCORE was provided,
which leads to under-prediction in high-risk patients.
Sensitivity analysis excluding this centre did not differ
from the analysis including it. The proportion of
patients lying above the risk level where the
additive EuroSCORE starts to underperform
(EuroSCORE ≥ 10%) was very small (0.62%, n = 689
of 110 769) [14, 20]. All centres were high-volume,
with only two having fewer than 800 cases per year,
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the largest high-volume threshold encountered in the
literature [21]. All centres exceeded the 400 cases
threshold recommended for cardiac operations by the
American Heart Association (AHA).
The yearly caseload varied considerably among sur-
geons and anaesthetists, both between and within
centres. Nevertheless, most surgeons (104/127, 81.9%)
can be considered high-volume as they performed
more than the 75 operations per year recommended by
the AHA. Likewise, most anaesthetists (150/190, 79%)
anaesthetised for more than 50 operations per year.
The logistic EuroSCORE was a signiﬁcant covari-
ate in both the three-level surgeon and anaesthetist
models for the in-hospital mortality outcome, adjusted
for the centre (OR 0.903 (95% CI 0.875–0.931) and
0.896 (95% CI 0.869–0.924), respectively; p value
< 0.0001 for both). The logistic EuroSCORE remained
signiﬁcant in the three-level, cross-classiﬁed model
adjusting for the surgeon and anaesthetist simultane-
ously (OR 0.903 (95% CI 0.876–0.930; p value
< 0.0001). The proportion of the variation in in-hospi-
tal death attributed to EuroSCORE (and other unex-
plained variables) from the three-level, cross-classiﬁed
model was 95.75% (Table 3).
Figure 2 shows the estimated probability of
in-hospital death for each surgeon if they operated on
a patient with the mean EuroSCORE (estimated at
7.4%), controlling for the centre effect only, and con-
trolling for both the centre and anaesthetist effects
simultaneously. Estimated probabilities of death for
eight out of 127 surgeons, from four different centres,
have their 95% CI lying wholly below the average
probability of death, indicating low mortality. There
were 19 surgeons from nine centres whose estimated
probability of death was higher than average. The sur-
geon random-effects variance was moderate but signiﬁ-
cant with ICCsurgeon = 0.0406, suggesting that 4.06% of
the variation in outcome was attributable to the oper-
ating surgeon (Table 3). Adjusting for anaesthetist did
not have an effect on the surgeon plots and reduced
ICCsurgeon slightly from 0.0406 to 0.0400, indicating
that the operating anaesthetist’s impact on the out-
Table 1 Characteristics of cardiac surgical patients and
procedure performed (n = 110 769). Values are mean
(SD) or number (proportion).
Age at admission; years 66.4 (11.3)
Logistic EuroSCORE; % 7.36 (9.88)
Male 80 603 (72.8%)
Priority
Elective 76 540 (69.1%)
Urgent 29 646 (26.8%)
Emergency 4123 (3.7%)
Salvage 419 (0.4%)
Unknown 41 (0.04%)
Operation type
Isolated CABG 57 644 (52.0%)
Isolated AVR 9956 (9.0%)
MVR 6475 (5.8%)
CABG + AVR 9050 (8.2%)
CABG + other 5466 (5.0%)
Other procedure 16 000 (14.4%)
Unknown 6178 (5.6%)
CABG, coronary artery bypass grafting; AVR, aortic valve
replacement or repair; MVR, mitral valve replacement or
repair.
Table 2 Numbers of patients operated on and surgeons and anaesthetists in each centre, between April 2002 and
March 2012. Surgeons and anaesthetists who looked after < 10 patients per year were excluded. Values are number
or mean (SD).
Centre no. Patients Surgeons Anaesthetists Deaths Mortality Logistic EuroSCORE
1 18 515 21 24 575 3.11% 8.07 (10.77)%
2 9633 13 16 273 2.83% 9.48 (12.26)%
3 6625 6 8 247 3.73% 8.23 (10.18)%
4 15 461 16 24 449 2.90% 6.16 (8.15)%
5 6907 10 15 220 3.19% 6.61 (9.00)%
6* 9900 10 17 243 2.45% 4.42 (3.35)%
7 7793 13 17 219 2.81% 7.99 (11.47)%
8 7501 11 13 215 2.87% 7.21 (10.91)%
9 17 112 17 22 577 3.37% 7.98 (10.54)%
10 11 322 10 34 395 3.49% 7.28 (8.58)%
*Additive EuroSCORE was provided by this centre (see text).
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come is minimal compared with that of the surgeon.
After adjusting for surgeon effects, there were no
remaining centre effects.
From the centre-anaesthetist model that adjusted
for patient risk, the anaesthetist random-effects variance
was very small (ICCanaesthetist = 0.0071). Figure 2c
demonstrates that there is almost no between-anaesthe-
tist variability in the outcome, with only one anaes-
thetist performing signiﬁcantly differently from the
average. In the cross-classiﬁcation model adjusting also
for surgeon effects, anaesthetist variation reduced to
ICCanaesthetist = 0.0025 which is negligible (Fig. 2d),
with no anaesthetist signiﬁcantly different from the
average. The ‘outlying’ anaesthetist in Fig. 2c performed
73% of his cases with the ‘worst’ performing surgeon in
his centre; it is thus possible that his results were driven
by the surgeon with whom he/she principally worked,
thus falsely appearing suboptimal compared with the
other anaesthetists. Once we adjusted for the surgeon as
well as the anaesthetist in the three-level, cross-classiﬁed
model, the impact of the surgeon on the anaesthetist’s
performance was accounted for and the speciﬁc anaes-
thetist was no longer signiﬁcantly different from average
(Fig. 2d). The difference in the probability of in-hospital
death between the two anaesthetists at the extremes
reduced from about 1.5% to 0.5%.
With respect to both surgeons and anaesthetists,
there was a weak association between increased vol-
ume of cases performed and reduction in mortality,
OR 0.99 (95% CI 0.96–1.01; p = 0.277) and 0.99 (95%
CI 0.98–1.01; p = 0.217), respectively (see Supporting
Information, Appendix S1).
Discussion
Our study cohort of 110 769 patients is the largest
study to date of the impact of individual anaesthetists
on patient outcome. This study includes data from ten
of the 36 UK cardiothoracic surgical centres and incor-
porates almost a third of all UK cardiac operations
Table 3 Variation in in-hospital death attributed to
each group. Values are proportion.
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Figure 2 Estimated probability of in-hospital death within three months of surgery for a patient with average Euro-
SCORE risk: (a) surgeons adjusted for centre only; (b) surgeons adjusted for centre and anaesthetist; (c) anaesthetists
adjusted for centre only; (d) anaesthetists adjusted for centre and surgeon. The horizontal line is average probability
(1.8%) for the study cohort. Error bars = 95% CI.
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undertaken during the one-decade study period.
Patient risk accounted for 95.75% of the variation in
in-hospital mortality. The second largest effect can be
ascribed to the surgeon (Table 3 based on the risk-
adjusted model adjusting for centre, surgeon and
anaesthetist). Adjusting for the anaesthetist and centre
components, the surgeon accounted for 4.00% of the
observed variation in-hospital mortality. In compar-
ison, the variation in mortality explained by the indi-
vidual anaesthetist was minimal (0.25%). There was no
remaining variation attributable to the centre.
Our key ﬁndings from a heterogeneous group of
ten UK centres were very similar to our previously
reported ﬁndings from a single, large, specialist cardio-
thoracic hospital [9]. Surgeons had a small but measur-
able effect on outcome, whereas no effect was found for
the anaesthetist. A literature review identiﬁed only one
other recent publication assessing the effect of the
anaesthetist on cardiac surgical outcomes. In contrast
to our ﬁndings, Glance et al. reported signiﬁcant varia-
tion in performance between anaesthetists [10]. Differ-
ent statistical methodology, study design and surgical
practices could account for these conﬂicting ﬁndings.
Glance et al. used a ﬁxed-effects model, which may not
have accounted for the simultaneous effects of the sur-
geon and the centre. In UK clinical practice, it is usu-
ally found that pairings between surgeons and
anaesthetists are not random, as they most often are in
the USA as reported by Glance et al. As shown by our
study, it is possible that part of the variation attributed
to the anaesthetist could be explained by the operating
surgeon, accounted for in our methodology by using
random-effects modelling accounting for all centre, sur-
geon and anaesthetist groupings simultaneously. The
principal advantage of our methodology is that it allows
the anaesthetist, surgeon or centre to be treated as a
random sample from the whole population; that is, if
we had chosen 190 other anaesthetists, the distribution
of their results would have been similar, yielding gener-
alisable estimates [22]. In contrast, ﬁxed-effects models
restrict results only to the sample of anaesthetists (sur-
geons or centres) available. Failure to take the depen-
dency between each group’s patients into account
during analysis may result in bias in the estimated
group and covariate effects, and inaccuracy in their
respective standard errors and p values [17]. Our
approach also allows us to delineate operator average
effects from the effect of their caseload volume. Differ-
ences in outcome measurements, anaesthetic practice,
training and size of surgical centre are additional fac-
tors that could explain the differences in ﬁndings.
Glance et al. used a composite outcome of in-hospital
mortality (no measurement period speciﬁed) and other
major complications on which the anaesthetist may be
more inﬂuential. No known risk score for this outcome
is available, although Glance et al. included several risk
factors in their analysis in order to adjust for differ-
ences in casemix. Anaesthetic care may be more stan-
dardised in UK centres than in the USA, thus allowing
less scope for variation in practice to be observed. In
the UK, consultants undertaking cardiothoracic anaes-
thesia have almost invariably undertaken additional
sub-speciality training. Although this is also the case
for US anaesthetists working in large surgical centres,
this may not be the case in many of the smaller US
surgical centres.
This study suggests that the standard of cardiac
anaesthetic care in the ten UK centres studied is con-
sistently high, but we acknowledge that these ﬁndings
may not apply elsewhere in the UK or worldwide. Our
study has demonstrated a robust mechanism for
detecting underperformance, and we recommend that
it should be applied to all UK centres with an interest
in the monitoring of anaesthetic performance [23].
Perhaps surprisingly, we found no evidence of
variation due to the centre. One potential limitation is
the possibility that centres that volunteered to partici-
pate were different, in terms of patient risk treated or
between-provider variability, from those opting not to
participate. It is possible that the small number of par-
ticipating centres and the potential bias due to their
self-selection may have resulted in underestimation of
the centre variation in our study. Furthermore, any
variation in centre performance might be accounted
for solely by variation in surgeon performance. More-
over, there is increasing evidence that anaesthetic care
may affect patient outcomes such as major postopera-
tive complications (e.g. stroke and myocardial infarc-
tion) [24]. A further limitation of our study is that we
did not consider such composite outcomes and we
underline the need for large studies on these to obtain
robust evidence of the relative impact of the anaes-
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thetist. The study was conducted in UK specialist car-
diothoracic centres, where anaesthetic practices are
often protocol-driven; this limits the potential for vari-
ation in the standard of care. Therefore, the ﬁndings
may not apply outside of the UK where practice may
differ. There was a small percentage (< 3.4%) of miss-
ing data in our dataset, which occurred mostly at the
start and end of the recorded series. Blocks of missing
data at the end of series are likely to have been due to
delays between completed hospital episodes and data
entry on to hospital electronic data systems. Moreover,
in some centres, the consistent recording of the logistic
EuroSCORE was not in place from the start of the ser-
ies (in 2002), resulting to some missing data. In both
these cases, missing data can be described as due to
administrative reasons and assumed to be missing
completely at random. Finally, in centre 6, one of the
participating surgeons omitted to record the speciﬁc
anaesthetist with whom he was principally working,
resulting in missing anaesthetist data; hence, we
excluded these records from further analysis. A sensi-
tivity analysis including this surgeon and imputing his
missing anaesthetist entries did not alter the results.
Professionals with very small caseloads were excluded
from analysis to avoid problems with model ﬁt due
zero events. However, as the exclusion of low-volume
professionals resulted in few exclusions (0.2%) and,
since mortality in this subset was comparable with that
of the full dataset (3.45% and 3.1%), it is unlikely that
this induced bias in the results.
This study was embarked upon by ACTA primar-
ily to answer two questions: (i) should individual
anaesthetists’ outcomes be published on the Internet?
and (ii) what is the safe minimum annual caseload?
Based on our ﬁndings, the answer to the ﬁrst question
is a resounding ‘no’ in the UK. Publication of these
results appears unnecessary and may have unintended
consequences, such as avoidance of high-risk cases,
already observed in cardiac surgical practice [25].
The second question is currently more difﬁcult to
answer. Our study suggests that performance is consis-
tent in anaesthetists who complete at least ten cases
per year and the second question is partially unre-
solved. Separate subgroup analysis of the combined
outcomes of our very low-volume UK colleagues is
probably required to answer this question. Although
there was a weak association between higher monthly
case volume and survival, our results suggest that
caseload may be less important than previously
thought. Increased morbidity (rather than death) asso-
ciated with low annual case volumes may be an addi-
tional reason for Glance’s et al.’s apparent conﬂicting
ﬁndings.
In conclusion, in the ten UK specialist centres
studied, the overwhelming factor associated with in-
hospital mortality was the patients’ risk proﬁle, with
the individual surgeon having a small but statistically
signiﬁcant contribution to variation in mortality. The
impact of the individual anaesthetist was minimal. The
operating centre did not have an effect on the out-
come. We propose that this study substantially vali-
dates current UK specialist training and practice in
cardiothoracic anaesthesia as ﬁt for purpose, at least as
far as it affects patient mortality. We recommend that
further study to examine the effect of cardiac anaes-
thetists on patient morbidity be carried out.
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